Moler, CA
Edward Moler, Emeryville, CA US
Patent application number | Description | Published |
---|---|---|
20100004253 | BIOMARKERS OF TARGET MODULATION, EFFICACY, DIAGNOSIS AND/OR PROGNOSIS FOR RAF INHIBITORS - Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to Raf kinase inhibition, are measured and identifications or adjustments may be made accordingly. | 01-07-2010 |
Edward Moler, Welnut Creek, CA US
Patent application number | Description | Published |
---|---|---|
20090297507 | ADAM10 in Cancer Diagnosis, Detection and Treatment - This invention is in the field of cancer-related genes. Specifically it relates to methods for detecting cancer or the likelihood of developing cancer based on the presence or absence of the ADAM10 gene or proteins encoded by this gene. The invention also provides methods and molecules for upregulating or downregulating the ADAM10 gene. | 12-03-2009 |
Edward Moler, Walnut Creek, CA US
Patent application number | Description | Published |
---|---|---|
20090036321 | Methods for predicting the course of a malignant disease - The present invention relates to methods of predicting the course of malignant disease and more specifically to methods which use SERPINE2 as a prognostic indicator of disease in cancer patients. | 02-05-2009 |
20090048266 | Effects of Inhibitors of Fgfr3 on Gene Transcription - Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to FGFR3 inhibition, are measured and identifications or adjustments may be made accordingly. | 02-19-2009 |
20090104193 | SEMA4D in Cancer Diagnosis, Detection and Treatment - This invention is in the field of cancer-related genes. Specifically it relates to methods for detecting cancer or the likelihood of developing cancer based on the presence or absence of the SEM A4D gene or proteins encoded by this gene. The invention also provides methods and molecules for upregulating or downregulating the SEMA4D gene. | 04-23-2009 |
20090214536 | CACNA1E in Cancer Diagnosis, Detection and Treatment - This invention is in the field of cancer-related genes. Specifically it relates to methods for detecting cancer or the likelihood of developing cancer based on the presence or absence of the CACNA1E gene or proteins encoded by this gene. The invention also provides methods and molecules for upregulating or downregulating the CACNA1E gene. | 08-27-2009 |
20120149714 | Effects of Inhibitors of FGFR3 on Gene Transcription - Methods of utilizing biomarkers to identify patients for treatment or to monitor response to treatment are taught herein. Alterations in levels of gene expression of the biomarkers, particularly in response to FGFR3 inhibition, are measured and identifications or adjustments may be made accordingly. | 06-14-2012 |
Edward J. Moler, Emeryville, CA US
Patent application number | Description | Published |
---|---|---|
20100075436 | METHODS FOR USE WITH NANOREACTORS - The invention relates to methods of using nanoreactor technology for sample analysis in microfluidic systems. | 03-25-2010 |
20100233187 | GENE PRODUCTS DIFFERENTIALLY EXPRESSED IN CANCEROUS CELLS - The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer. | 09-16-2010 |
20120308569 | GENE PRODUCTS DIFFERENTIALLY EXPRESSED IN CANCEROUS CELLS - The present invention provides polynucleotides, as well as polypeptides encoded thereby, that are differentially expressed in cancer cells. These polynucleotides are useful in a variety of diagnostic and therapeutic methods. The present invention further provides methods of reducing growth of cancer cells. These methods are useful for treating cancer. | 12-06-2012 |
20120322065 | Methods for Use with Nanoreactors - The invention relates to methods of using nanoreactor technology for sample analysis in microfluidic systems. | 12-20-2012 |